Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-03-12

Clinical Trial Update: Inflammation REduction to Prevent cArdiovascular Injury in Renal Disease (REPAIR) [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update for REPAIR, investigating inflammation reduction to prevent cardiovascular injury in chronic kidney disease/renal failure, current…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Hamilton Health Sciences Corporation | Conditions: Chronic Kidney Diseases, Renal Failure | Phase 1 | Status: RECRUITING